GENE ONLINE|News &
Opinion
Blog

2026-02-03|

Weatherford International Reports $1.25 Billion Q4 Revenue and $520 Million Full-Year Net Income for 2025

by GOAI
Share To

Weatherford International released its financial results for the fourth quarter and full year of 2025. The company reported a total revenue of $1.25 billion for the fourth quarter, reflecting a 10% increase compared to the same period in 2024. For the full year, Weatherford achieved a total revenue of $4.8 billion, marking an 8% growth from the previous year.

The company attributed this growth to increased activity across its core business segments and improved operational efficiencies. In addition to revenue gains, Weatherford reported a net income of $150 million for the fourth quarter, compared to $120 million in Q4 2024. Full-year net income reached $520 million, up from $450 million in 2024. The company also highlighted improvements in free cash flow generation and reductions in debt levels during the reporting period.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 3, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
NETSTREIT Corp Announces Upsized Forward Sale of 11 Million Shares at $18.90 Each
2026-02-11
Copart to Release Q2 Fiscal Year 2026 Financial Results on February 12 at 3:05 AM GMT
2026-02-11
BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations
2026-02-11
Shriners Children’s Launches Multi-Center Study on Fractional CO2 Laser Technology for Pediatric Burn Care
2026-02-11
Rising Lung Cancer Cases Among Non-Smokers Linked to Genetic and Environmental Factors
2026-02-11
Path Planning Transformer Introduced to Enhance Multi-Robot Navigation in Complex Environments
2026-02-11
Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top